Kbc Group Nv West Pharmaceutical Services Inc Transaction History

Kbc Group Nv

$32.2 Billion
Q1 2025

A detailed history of Kbc Group Nv transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Kbc Group Nv holds 10,612 shares of WST stock, worth $2.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,612

Previous 9,980 6.33%

Holding current value

$2.24 Million

Previous $3.27 Million 27.32%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$199.11 - $347.87 $125,837 - $219,853	632 Added 6.33%	10,612 $2.38 Million
Q4 2024 Jan 22, 2025	BUY	$285.69 - $344.0 $11,998 - $14,448	42 Added 0.42%	9,980 $3.27 Million
Q3 2024 Nov 06, 2024	SELL	$277.16 - $333.3 $2.06 Million - $2.48 Million	-7,441 Reduced 42.82%	9,938 $2.98 Million
Q2 2024 Jul 17, 2024	SELL	$314.68 - $395.94 $618,031 - $777,626	-1,964 Reduced 10.15%	17,379 $5.72 Million
Q1 2024 May 08, 2024	SELL	$338.27 - $413.0 $28.5 Million - $34.8 Million	-84,221 Reduced 81.32%	19,343 $7.65 Million
Q4 2023 Feb 13, 2024	SELL	$318.29 - $392.21 $414,095 - $510,265	-1,301 Reduced 1.24%	103,564 $36.5 Million
Q3 2023 Feb 15, 2024	BUY	$354.9 - $412.41 $1.87 Million - $2.17 Million	5,267 Added 4.95%	111,570 $41.9 Million
Q2 2023 Feb 15, 2024	BUY	$334.63 - $382.47 $13.9 Million - $15.9 Million	41,503 Added 64.05%	106,303 $40.7 Million
Q2 2023 Jul 28, 2023	BUY	$334.63 - $382.47 $20 Million - $22.9 Million	59,843 Added 132.92%	104,865 $40.1 Million
Q1 2023 Feb 14, 2024	BUY	$232.5 - $346.47 $770,737 - $1.15 Million	3,315 Added 7.75%	46,073 $16 Million
Q1 2023 May 04, 2023	SELL	$232.5 - $346.47 $4.24 Million - $6.32 Million	-18,238 Reduced 28.83%	45,022 $15.6 Million
Q4 2022 Feb 14, 2024	SELL	$209.34 - $261.61 $5.05 Million - $6.31 Million	-24,127 Reduced 36.07%	42,758 $10.1 Million
Q3 2022 Feb 15, 2024	SELL	$246.08 - $343.65 $9.54 Million - $13.3 Million	-38,764 Reduced 37.43%	64,800 $15.9 Million
Q3 2022 Nov 08, 2022	SELL	$246.08 - $343.65 $404,801 - $565,304	-1,645 Reduced 2.53%	63,260 $15.6 Million
Q2 2022 Feb 14, 2024	SELL	$280.61 - $420.45 $270,227 - $404,893	-963 Reduced 1.42%	66,885 $20.2 Million
Q2 2022 Jul 26, 2022	SELL	$280.61 - $420.45 $825,835 - $1.24 Million	-2,943 Reduced 4.34%	64,905 $19.6 Million
Q1 2022 Feb 14, 2024	SELL	$357.49 - $445.92 $14.4 Million - $17.9 Million	-40,227 Reduced 37.22%	67,848 $27.9 Million
Q1 2022 May 06, 2022	SELL	$357.49 - $445.92 $14.4 Million - $17.9 Million	-40,227 Reduced 37.22%	67,848 $27.9 Million
Q4 2021 Feb 14, 2024	BUY	$402.25 - $471.34 $1.81 Million - $2.13 Million	4,511 Added 4.36%	108,075 $50.7 Million
Q4 2021 Feb 03, 2022	SELL	$402.25 - $471.34 $674,975 - $790,908	-1,678 Reduced 1.53%	108,075 $50.7 Million
Q3 2021 Nov 10, 2021	SELL	$363.01 - $468.47 $6.06 Million - $7.83 Million	-16,706 Reduced 13.21%	109,753 $46.6 Million
Q2 2021 Aug 11, 2021	SELL	$284.77 - $363.2 $1.49 Million - $1.9 Million	-5,233 Reduced 3.97%	126,459 $45.4 Million
Q1 2021 Apr 26, 2021	BUY	$257.29 - $307.53 $8.41 Million - $10 Million	32,668 Added 32.99%	131,692 $37.1 Million
Q4 2020 Feb 10, 2021	SELL	$261.16 - $301.66 $14.6 Million - $16.8 Million	-55,819 Reduced 36.05%	99,024 $28.1 Million
Q3 2020 Oct 28, 2020	BUY	$224.99 - $288.02 $9.81 Million - $12.6 Million	43,624 Added 39.22%	154,843 $42.6 Million
Q2 2020 Aug 10, 2020	BUY	$149.8 - $227.17 $8.92 Million - $13.5 Million	59,546 Added 115.24%	111,219 $25.3 Million
Q1 2020 May 04, 2020	BUY	$128.96 - $174.76 $5.98 Million - $8.11 Million	46,391 Added 878.28%	51,673 $7.87 Million
Q4 2019 Feb 11, 2020	BUY	$137.6 - $151.21 $726,803 - $798,691	5,282 New	5,282 $794,000

Others Institutions Holding WST

# of Institutions

806

Shares Held

66.5M

Call Options Held

244K

Put Options Held

424K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $15.6B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account